20 closest matches · ranked by relevance
Sarcopenia
Primary: Serum Total Testosterone Measured Before Treatment on Treatment Day 1 (Baseline Study) — 307.57; 363.43; 408.17; 318.68 ng/dL
Male Hypogonadism · Muscle Atrophy · Sarcopenia
Primary: 1 Repetition Maximum (1-RM) Strength Testing — 129.1; 109.4; 137.2; 118.8 kg — p=<0.001
Abuse of Anabolic Steroids
Primary: Steroid Levels in Urine Steroid Profile — 69.5773456; 138.0291641; 163.117081; 107.7160658 ng/mL
Caloric Restriction · Exercise
Primary: Body Composition at the End of Each Study Phase — 78.3; 78.0; 73.3; 75.8 kilograms
Anorexia Nervosa
Primary: Bone Mineral Density — 3.2; -0.6 percent change — p=<0.0001
HIV Infection
Primary: Lean Body Mass — 1.8; 0.8 kilograms — p=0.04
Adrenal Insufficiency
Primary: Number of Participants With Adrenal Insufficiency — 7 participants
Hypogonadism
Primary: The Area Under the Curve From Time Zero to Last Quantifiable Concentration [AUC (0-t)] of Testosterone Enanthate Formulations at 6 Weeks — 150445.2; 70955.7; 278657.9…
Osteoarthritis
Primary: Change in Serum Osteocalcin — -2.18; -0.45; -1.10 ng/mL
Hypogonadism
Primary: Maximum Concentration (Cmax) for Serum Testosterone and Testosterone Enanthate — 773.7; 1487.0; 49.25; 267.33 ng/dL
Muscle Atrophy · ACL Reconstruction · Trauma
Primary: Changes in Lean Mass — 2.8; -0.1; 2.16; 0.01 kg — p=0.35
Inhospital Cardiac Arrest
Primary: Early Postresuscitation Arterial Blood Pressure (mmHg) Measured Through Institution of Invasive Intra-arterial Pressure Monitoring (as Feasible). — 78.4; 75.1 mmHg…
Opioid-Related Disorders · Substance-Related Disorders
Primary: Breakpoint — 25; 400; 1400; 850 Mouse Clicks
Healthy Males · Male Contraceptive
Primary: Maximum Testosterone Concentration — 471; 444; 543 ng*hr/dL
Hypogonadism, Male · Physical Activity · Testosterone Deficiency
Primary: Change From Baseline in Lean Mass — 2734; 499; 2268 grams
Depression · Substance Abuse · Substance Use
Primary: HAMD Rating Scores — 16.86; 10.71; 9.81; 7.33 Units on a scale
Other Complication of Kidney Transplant · Renal Transplant Rejection
Primary: Cases of Kidney Transplant Patients With DSA — 0; 0 Participants
Total Hip Replacement
Primary: Serum Prothrombin Fragment 1 and 2 (PF 1.2) — 334.15; 298.12; 778.33; 619.21 pmol/mL
Hypogonadism
Primary: Number of Patients With Adverse Events Receiving Testosterone Enanthate Via QST Auto-injector. — 5; 1; 0; 0 Participants
Hypogonadism
Primary: Changes in Basal Muscle Protein Synthesis and Breakdown as Measured by Stable Isotope Metabolic Studies at Baseline and at Five Months — 0.05; 0.06; 0.06; 0.066 Percent…